多发性创伤合并胸部创伤患者中CYFRA 21-1、血管生成素-2、正五聚蛋白-3、sRAGE、IL-6和IL-10的评估——预测肺炎的有用标志物吗?
本研究为回顾性分析前瞻性收集的数据,纳入多发性创伤合并胸部创伤患者(损伤严重度评分≥16,胸部简明损伤定级≥3),分为肺炎组和无肺炎组,在到达创伤抢救室时及第2天、第5天检测肺上皮标志物CYFRA 21-1、内皮标志物Ang-2及炎症标志物PTX-3、sRAGE、IL-6、IL-10。共纳入73例患者和16例健康对照,20例(27.4%)发生肺炎。多发性创伤患者CYFRA 21-1水平较健康对照显著升高,入院后出现明显峰值;PTX-3在第2天较健康对照显著升高。肺炎组与无肺炎组间各标志物在所有时间点均无统计学显著差异。逻辑回归显示IL-6、IL-10、sRAGE和PTX-3联合可能有助于识别肺炎风险,新开发的评分在发生肺炎的患者第0天显著更高(P < 0.05)。结论认为单个标志物无帮助,而联合可能有用。
要点
- 多发性创伤合并胸部创伤患者中,肺炎组与无肺炎组间CYFRA 21-1、Ang-2、PTX-3、sRAGE、IL-6、IL-10在各时间点均无统计学显著差异。
- 多发性创伤患者CYFRA 21-1水平较健康对照显著升高,入院后出现明显峰值。
- PTX-3在第2天较健康对照显著升高。
- IL-6、IL-10、sRAGE和PTX-3联合评分在发生肺炎的患者第0天显著更高(P < 0.05)。
- 单个血清标志物不能识别多发性创伤后肺炎风险,联合评分可能有助于识别。
适用人群与场景
- 多发性创伤合并胸部创伤患者(损伤严重度评分≥16,胸部简明损伤定级≥3)。
- 场景:到达创伤抢救室时及住院第2天、第5天。
诊断标准与关键阈值
- 纳入标准:损伤严重度评分≥16,胸部简明损伤定级≥3。
- 肺炎诊断依据临床病程中是否发生肺炎。
研究设计与关键结果
- 研究类型:回顾性分析前瞻性收集的数据;样本量:73例患者和16例健康对照;20例(27.4%)发生肺炎。
- 多发性创伤患者CYFRA 21-1水平较健康对照显著升高,入院后出现明显峰值。
- PTX-3在第2天较健康对照显著升高。
- 肺炎组与无肺炎组间CYFRA 21-1、Ang-2、PTX-3、sRAGE、IL-6、IL-10在所有天数均无统计学显著差异。
- 逻辑回归显示IL-6、IL-10、sRAGE和PTX-3联合可能有助于识别肺炎风险,新评分在发生肺炎的患者第0天显著更高(P < 0.05)。
- 损伤严重度评分和人口学参数在肺炎组与无肺炎组间相当。
证据类型、等级与局限
- 证据类型:回顾性分析前瞻性收集的数据。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,所研究的单个血清标志物不能帮助识别多发性创伤后肺炎风险,而IL-6、IL-10、PTX-3和sRAGE联合可能有助于识别。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Background: Pneumonia is a frequent complication after polytrauma. This study aims to evaluate the ability of different serum markers to identify patients at risk of developing pneumonia after polytrauma. Methods: A retrospective analysis of prospectively collected data in polytraumatized patients with concomitant thoracic trauma (Injury Severity Score ≥16, Abbreviated Injury Scale Thorax ≥ 3) was performed. The study cohort was divided into patients with and without pneumonia during the clinical course. Serum levels of lung epithelial (CYFRA 21-1), endothelial (Ang-2), and inflammatory (PTX-3, sRAGE, IL-6, IL-10) markers were measured upon arrival in the trauma room and on days 2 and 5. Results: A total of 73 patients and 16 healthy controls were included in this study. Of these, 20 patients (27.4%) developed pneumonia. Polytraumatized patients showed significantly increased CYFRA 21-1 levels with a distinct peak after admission compared with healthy controls. Serum PTX-3 significantly increased on day 2 in polytraumatized patients compared with healthy controls. Injury Severity Score and demographic parameters were comparable between both groups (pneumonia vs. no pneumonia). No statistically significant difference could be observed for serum levels of CYFRA 21-1, Ang-2, PTX-3, sRAGE, IL-6, and IL-10 between the groups (pneumonia vs. no pneumonia) on all days. Logistic regression revealed a combination of IL-6, IL-10, sRAGE, and PTX-3 to be eventually helpful to identify patients at risk of developing pneumonia and our newly developed score was significantly higher on day 0 in patients developing pneumonia ( P < 0.05). Conclusion: The investigated serum markers alone are not helpful to identify polytraumatized patients at risk of developing pneumonia, while a combination of IL-6, IL-10, PTX-3, and sRAGE might be.
参考来源
- Vollrath JT, Schindler CR, Herrmann E, et al. EVALUATION OF CYFRA 21-1, ANGIOPOETIN-2, PENTRAXIN-3, SRAGE, IL-6, AND IL-10 IN POLYTRAUMATIZED PATIENTS WITH CONCOMITANT THORACIC TRAUMA-HELPFUL MARKERS TO PREDICT PNEUMONIA? Shock. 2023. PMID: 37548620. doi:10.1097/SHK.0000000000002186
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。